Total RNA Purification Kits
For research use only and NOT intended for in vitro diagnostics.
CE-IVDR marked diagnostic version available here
For research use only and NOT intended for in vitro diagnostics.
CE-IVDR marked diagnostic version available here
Register today to receive an exclusive 15% off* on your first order.
These kits are suitable for the isolation of total RNA from a range of samples including cells, bacteria, yeast, virus and bodily fluids including plasma/serum, blood, saliva, CSF and more. Extract high quality and purity RNA with excellent RIN values and A260/A280 suitable for downstream applications including qRT-PCR, RT-PCR, microarrays, NGS and more. These kits purify all sizes of RNA from large mRNA, lncRNA down to microRNA (miRNA) in the same fraction without the requirement of phenol. Isolate all RNA sequences at an equal rate irrespective of size. Moreover, when the RNA sequences are small (e.g. miRNA), the column binds small RNAs regardless of their GC content.
Total RNA Purification 96-Well Kit (High Throughput and High Throughput Deep Well)
This 96-well kit provides a rapid method for the high-throughput isolation and purification of total RNA in 30 minutes using vacuum manifold, plate centrifuge, or liquid handlers with vacuum capabilities. Total RNA can be isolated from a broad range of sample sources including cultured cells, tissues, blood, serum, plasma, bacteria, yeast, fungi, and viruses.
Isolate RNA after Purifying EVs and Exosomes
Ultracentrifugation, Exoquick, Filtration
Cat. # | Name | Elution Volume | Plasma/Serum | Urine | Cell-Culture Media |
---|---|---|---|---|---|
55000 | Plasma/Serum RNA Purification Mini Kit | 10 - 25 µL | 50 µL - 1 mL | 250 µL - 1 mL | 5 - 10 mL |
35300 | Total RNA Purification Micro Kit | 20 - 50 µL | 1 - 4 mL | 2 - 10 mL | 10 - 20 mL |
17200 | Total RNA Purification Kit | 50 - 100 µL | 4 - 10 mL | 11 - 30 mL | 20 - 35 mL |
Kit Specifications
|
|
Maximum Binding Capacity
|
Up to 50 μg RNA
|
Maximum Loading Volume
|
650 μL
|
Size of RNA Purified
|
All sizes, including small RNA (< 200 nt)
|
Maximum Amount of Starting Material
|
|
Animal Cells | 3 x 106 cells |
Animal Tissues | 10 mg (for most tissues*) |
Blood | 100 μL |
Plasma/Serum | 200 μL |
Bacteria | 1 x 109 cells |
Yeast |
1 x 108 cells
|
Fungi |
50 mg
|
Plant Tissues |
50 mg
|
Time to Complete 10 Purifications |
20 minutes
|
Average Yield | |
HeLa Cells (1 x 106 cells) | 15 μg |
E. coli (1 x 109 cells) | 50 μg |
* for isolating total RNA from larger amounts of tissue, please use Norgen's Animal Tissue RNA Purification Kit (Cat# 25700)
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. These kits are stable for 2 years after the date of shipment.
Component | Cat. 17200 (50 preps) | Cat. 37500 (100 preps) | Cat. 17250 (250 preps) | Cat. 17270 (500 preps) | Cat. 24300 (192 preps) | Cat. 24370 (576 preps) | Cat. 24350 (192 preps) | Cat. 24380 (576 preps) |
---|---|---|---|---|---|---|---|---|
Buffer RL | 40 mL | 2 x 40 mL | 175 mL | 350 mL | 2 x 40 mL | 350 mL | 2 x 40 mL | 350 mL |
Wash Solution A | 38 mL | 2 x 38 mL | 148 mL | 1 x 148 mL 1 x 74 mL |
2 x 38 mL | 1 x 74 mL 1 x 148 mL |
2 x 38 mL | 1 x 74 mL 1 x 148 mL |
Elution Solution A | 6 mL | 2 x 6 mL | 30 mL | 60 mL | 2 x 20 mL | 60 mL | 2 x 20 mL | 60 mL |
Mini Spin Columns | 50 | 100 | 250 | 500 | - | - | - | - |
96-Well Isolation Plate | - | - | - | - | 2 | 6 | - | - |
96-Well Isolation Plate (Deep Well) | - | - | - | - | - | - | 2 | 6 |
Adhesive Tape | - | - | - | - | 4 | 12 | 4 | 12 |
Collection Tubes | 50 | 100 | 250 | 500 | - | - | ||
96-Well Collection Plate | - | - | - | - | 2 | 6 | - | - |
96-Well Collection Plate (Deep Well) | - | - | - | - | - | - | 2 | 6 |
Elution Tubes (1.7 mL) | 50 | 100 | 250 | 500 | - | - | ||
96-Well Elution Plate | - | - | - | - | 2 | 6 | - | - |
96-Well Elution Plate (Deep Well) | - | - | - | - | - | - | 2 | 6 |
Product Insert | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Poor RNA recovery could be due to one or more of the following:
Column/well clogging can result from one or combination of the following factors:
RNA can be degraded due to the following factors:
If the RNA does not perform well in downstream applications, it may be due to one or more of the following:
The contamination with genomic DNA may be due to large amount of starting material used. Perform RNase-free DNase I digestion on the RNA sample after elution to remove genomic DNA contamination. It is recommended that Norgen’s RNase-Free DNase I Kit (Product # 25710) be used for this step.
Yes, the Total RNA purification kits can be used to purify RNA from samples like buffy coats and isolated PBMCs. For blood leukocyte samples, you can use a specialized product - Leukocyte RNA purification kit.
Yes, Total RNA purification kits can be used with samples stored in RNA protective agents like RNAlater. Norgen Biotek also provides a similar RNA preserve solution (Cat. 17260).
Yes, you can use Total RNA purification kits to purify RNA from insect samples. Please contact our Tech support team at support@norgenbiotek.com and ask for reference publications.
Yes, lysates prepared in buffer RL can be frozen at -80°C, and the remaining protocol can be performed at a later date.
Yes, you can use Norgen's Total RNA purification kits with the aqueous phase from samples prepared in TRIzol. Please contact our Tech Support team at support@norgenbiotek.com if you have any questions regarding the protocol.
Yes, Norgen Total RNA purification kits are compatible with tissue samples stored in OCT compound. Please contact our Tech Support team at support@norgenbiotek.com and ask for reference publications.
Title | Nanoparticle-based delivery of harmine: A comprehensive study on synthesis, characterization, anticancer activity, angiogenesis and toxicity Evaluation |
Citation | A Cell Press journal 2024. |
Authors | Faezeh Mohammadi Negar Ghaleh navi Ehsan Karimi Masoud Homayouni-Tabrizi Ehsan Oskoueian |
Title | Circulatory miR-133a and miR-145 are Associated with the Improving Impact of Combined Endurance Exercise and MitoQ on Cardiovascular Function in Patients with Hypertension |
Citation | Brazilian Archives of Biology and Technology 2024. |
Authors | Yaser Masoumi-Ardakani, Hamid Najafipour, Hamid Reza Nasri, Beydolah Shahouzehi, Najmeh Noohi |
Title | Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces |
Citation | Cell Nature Biology 2024. |
Authors | Patrizia Romani, Giada Benedetti, Martina Cusan, Mattia Arboit, Carmine Cirillo, Xi Wu, Georgia Rouni, Vassiliki Kostourou, Mariaceleste Aragona, Costanza Giampietro, Paolo Grumati, Graziano Martello & Sirio Dupont |
Title | Modulation of cAMP/cGMP signaling as prevention of congenital heart defects in Pde2A deficient embryos: a matter of oxidative stress |
Citation | Cell death and disease 2024. |
Authors | Silvia Cardarelli, Martina Biglietto, Tiziana Orsini, Valentina Fustaino, Lucia Monaco, Ana Gabriela de Oliveira do Rêgo, Francesca Liccardo, Silvia Masciarelli, Francesco Fazi, Fabio Naro, Luciana De Angelis & Manuela Pellegrini |
Title | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease |
Citation | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024. |
Authors | Martina Sevegnani a 1, Adriano Lama a 1, Francesco Girardi a, Michael W. Hess b, Maria Paulina Castelo c, Irene Pichler c, Stefano Biressi a, Giovanni Piccoli |
Title | CircZFR promotes colorectal cancer progression via stabilizing BCLAF1 and regulating the miR-3127-5p/RTKN2 axis |
Citation | scientific reports 2024. |
Authors | Lihong Yang, Yong Ruan, Bin Chen, Yuhang Zhu & Houqiang Xu |
Title | Human-rat integrated microRNAs profiling identified a new neonatal cerebral hypoxic-ischemic pathway melatonin-sensitive |
Citation | Journal of Pineal Research 2024. |
Authors | Michael D. Weiss, Silvia Carloni, Tania Vanzolini, Sofia Coppari, Walter Balduini, Giuseppe Buonocore, Mariangela Longini, Serafina Perrone, Livia Sura, Atefeh Mohammadi, Marco Bruno Luigi Rocchi, Massimo Negrini, Davide Melandri, Maria Cristina Albertini |
Title | Molecular Characterization of Acute Bee Paralysis Virus (ABPV) and Black Queen Cell Virus (BQCV) in Honeybees (Apis mellifera L. (Hymenoptera: Apidae)) from the Campinas Region |
Citation | Sociobiology 2024. |
Authors | Márcia F. Nogueira1,2, Camila D. Malossi3, Maria Giulia B. Frediani2, David Pereira2, Simone de S. Prado2, João P. Araujo Jr.3, Cristiano Menezes2 |
Title | Probabilistic association of differentially expressed genes with cis-regulatory elements |
Citation | Genome Research 2024. |
Authors | Brian S Roberts, Ashlyn G Anderson, Chris Partridge, Gregory M Cooper and Richard M. Myers |
Title | PnNAC2 promotes the biosynthesis of Panax notoginseng saponins and induces early flowering |
Citation | Plant Cell Reports 2024. |
Authors | Yuying Huang, Yue Shi, Xiuhua Hu, Xiaoqin Zhang, Xin Wang, Shanhu Liu, Gaojie He, Kelu An, Fanyuan Guan, Yuyan Zheng, Xiaohui Wang & Shengli Wei |